
China TransInfo Technology Hits Day High with 4.49% Surge in Stock Price
2025-10-23 17:50:11China TransInfo Technology Co., Ltd. saw a significant rise in stock price on October 22, 2025, amid a positive month and year-to-date performance. However, the company has struggled with declining long-term performance and profitability concerns, reporting negative results for the past three quarters and a low Return on Capital Employed.
Read More
China TransInfo Hits Day Low of CNY 11.12 Amid Price Pressure
2025-10-15 17:51:37China TransInfo Technology Co., Ltd. faced a significant stock decline on October 14, 2025, amid ongoing challenges. The company has reported negative results for three consecutive quarters, with declining net sales and low management efficiency. Despite some recent gains, long-term performance remains concerning, reflecting high risk in current trading conditions.
Read More
China TransInfo Technology Hits Day Low of CNY 10.93 Amid Price Pressure
2025-10-14 19:50:39China TransInfo Technology Co., Ltd. saw its stock decline significantly today, contrasting with the broader market's performance. Despite a positive monthly trend, the company has struggled with declining net sales and operating profit over five years, alongside negative results for the past three quarters, raising concerns about its financial health.
Read More
China TransInfo Technology Hits Day High with 4.54% Surge in Stock Price
2025-10-01 17:13:12China TransInfo Technology Co., Ltd. saw a significant rise on September 30, 2025, outperforming the Shanghai Composite index. Over the past year, the company has achieved a notable increase, despite facing challenges such as declining net sales and low profitability. It maintains a high dividend yield in a competitive market.
Read More
China TransInfo Technology Hits Day Low of CNY 11.00 Amid Price Pressure
2025-09-29 15:27:09China TransInfo Technology Co., Ltd. saw its stock price decline significantly today, contrasting with the broader market's performance. Despite a recent weekly gain, the company faces challenges with declining net sales and low profitability metrics, raising concerns about its financial health and necessitating a potential strategic reassessment.
Read More





